TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants July 11, 2014
Spotlight ArticleTCL Archive Rose Kushner, Author, Advocate, Dead At 60 Of Breast Cancer January 19, 1990
